Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price?

The weight loss drug company continues to make progress, but its share price is bouncing around with events.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Friday 2 October →